Uromitexan Infusion
Prescription Required
Product introduction
Uromitexan Infusion is used to prevent ifosfamide-induced hemorrhagic cystitis (bleeding in the bladder that may be caused as a side effect due to treatment with a cancer chemotherapy drug called ifosfamide). However, it is not used to reduce the risk of bladder bleeding due to other medical conditions.
It is a cytoprotective medicine.
It is a cytoprotective medicine.
Uses of Uromitexan Infusion
Benefits of Uromitexan Infusion
In Treatment of Ifosfamide-induced hemorrhagic cystitis
Ifosfamide-induced hemorrhagic cystitis is an inflammatory condition due to the use of a medicine called Ifosfamide that causes bleeding in the bladder. Uromitexan Infusion helps to suppress the body’s immune system, thereby reducing the progression of the disease. It reduces the inflammation of the damaged area, prevents further damage, and stabilises your condition
How to use Uromitexan Infusion
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Uromitexan Infusion. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Uromitexan Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
UNSAFE
Uromitexan Infusion is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Uromitexan Infusion may cause side effects which could affect your ability to drive.
As patients undergoing treatment with Uromitexan Infusion may experience undesirable effects such as lightheadedness, lethargy, dizziness, and blurred vision which could affect the ability to drive.
As patients undergoing treatment with Uromitexan Infusion may experience undesirable effects such as lightheadedness, lethargy, dizziness, and blurred vision which could affect the ability to drive.
Kidney
CAUTION
Uromitexan Infusion should be used with caution in patients with kidney disease. Dose adjustment of Uromitexan Infusion may be needed. Please consult your doctor.
Liver
CAUTION
Uromitexan Infusion should be used with caution in patients with liver disease. Dose adjustment of Uromitexan Infusion may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Uromitexan Infusion is given as in injection or infusion under the supervision of a doctor only.
- Do not skip any dose and complete the course as suggested by your doctor.
- It is advisable to drink plenty of water to stay hydrated while taking this medicine.
- Your doctor may get a regular urine and blood tests done to monitor your blood cell count (CBC).
Fact Box
Chemical Class
Sulfhydryl compound, {organosulfonic acid}
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Cytoprotective agents- Bladder
Patient concerns
FAQs
Why it is given with ifosamide or cyclophosphamise (Cytoxan)?
It is given along with the chemotherapy drug ifosfamide or cyclophosphamide to reduce the side effects of these drugs
Is mesna compatible with potassium chloride and doxorubicin?
Yes, Mesna is compatible with potassium chloride and doxorubicin
Is Uromitexan Infusion a chemotherapy drug?
Uromitexan Infusion is not a chemotherapy drug
Is Uromitexan Infusion cytotoxic?
No. Uromitexan Infusion is not cytotoxic drug. It is cytoprotective drug
Is Uromitexan Infusion a vesicant?
No, Uromitexan Infusion is not a vesicant.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 870-71.
- Mesna. Thetford, Norfolk: Baxter Healthcare Ltd.; 2003 [revised Oct. 2014]. [Accessed 28 Jan. 2019] (Online) Available from:
- Mesna. Los Angeles, California: American pharmaceutical partners; 2001. [Accessed 26 Mar. 2019] (online) Available from:
- Medscape. Mesna. [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Zydus Cadila
Address: Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
52 people viewed this recentlyMRP
₹31.96
Inclusive of all taxes
2.0 ml in 1 bottle
SOLD OUT